A prospective cohort study on rivaroxaban in the prevention of catheter-related thrombosis in breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
First-degree relatives experienced an MS incidence of 211 per 100,000 per year, roughly 100-fold above sporadic MS rates, with median 2-year time to conversion and diagnosis at 37. Evolving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results